Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 4Neoplasm Metastasis 2Rheumatoid Arthritis, Systemic Juvenile 1Periodic Fevers Syndrome 1Mevalonate Kinase Deficiency 1Metastatic Pancreatic Ductal Adenocarcinoma 1Melanoma 1Cryopyrin-Associated Periodic Syndromes 1Carcinoma 1Bronchiolitis Obliterans Syndrome 1Arthritis, Juvenile 1Arthralgia 1

Interventions

secukinumab 1canakinumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Periodic Fevers Syndrome × canakinumab × Clear all
NCT02911857 2018-08-20

An Extention Study of Safety of Canakinumab in Japanese Patients With Periodic Fever Syndromes

Novartis

Phase 3 Completed
4 enrolled 7 charts

Periodic Fevers Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡